TTF1-positive SMARCA4/BRG1 deficient lung adenocarcinoma
SMARCA4/BRG1-deficient lung adenocarcinoma (SD-LUAD) is being recognized as a distinct subtype based on subtle differences in its clinical, morphological, and immunophenotypic attributes compared to other non–small cell lung carcinomas. We present here a case of SD-LUAD with curious thyroid transcri...
Main Authors: | Anurag Mehta, Himanshi Diwan, Divya Bansal, Manoj Gupta |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society of Pathologists & the Korean Society for Cytopathology
2022-01-01
|
Series: | Journal of Pathology and Translational Medicine |
Subjects: | |
Online Access: | http://www.jpatholtm.org/upload/pdf/jptm-2021-09-16.pdf |
Similar Items
-
Case Report: SMARCA4 (BRG1)-deficient undifferentiated carcinoma of gallbladder with genetic analysis
by: Xiangpeng Meng, et al.
Published: (2023-06-01) -
Clinical characteristics and prognostic analysis of SMARCA4‐deficient non‐small cell lung cancer
by: Xiyue Liang, et al.
Published: (2023-07-01) -
BRG1: Promoter or Suppressor of Cancer? The Outcome of BRG1’s Interaction with Specific Cellular Pathways
by: Aaron Shaykevich, et al.
Published: (2023-02-01) -
Thoracic SMARCA4-deficient tumors: a clinicopathological analysis of 52 cases with SMARCA4-deficient non-small cell lung cancer and 20 cases with thoracic SMARCA4-deficient undifferentiated tumor
by: Ping Zhou, et al.
Published: (2024-02-01) -
Case report: Heterogenous SMARCA4-deficient thoracic non-small cell lung carcinoma with various responses to nivolumab
by: Yun-Tzu Lin, et al.
Published: (2023-03-01)